This protocol is judged by an institutional critique board, an impartial group that assessments any scientific trials involving people. If a study consists of a Program I drug, once the board approves the protocol as ethical, the scientists really have to submit an application for an investigational new drug (IND) number from the FDA.Weiser urged s